.
– With sales of CHF 48.5 million and EBIT of CHF 10.5 million, results exceeded Management expectations
– For the first time in two years, Micronas posts a quarterly profit For the year as a whole, the Board of Directors and Management expect sales of around CHF 190 million, an EBIT margin of 12 percent, and a positive overall result
Micronas has posted consolidated net sales of CHF 48.5 million for the third quarter of 2010, which is around the same as the previous qu
SAP AG (NYSE: SAP), the world-s leading provider of business software, will release its results for the third quarter of 2010 on Wednesday, October 27, before the opening of the Frankfurt Stock Exchange.
Later that day, SAP-s Co-CEOs Jim-Hagemann Snabe and Bill McDermott and CFO Werner Brandt, will host a press conference call and a financial analyst conference call to review the results and discuss the company-s business performance.
Salamander Industrie-Produkte GmbH, manufacturer of PVC profiles for windows and doors opened a state-of-the-art mixing facility for hard PVC and additives at the production plant of its subsidiary Brügmann S.A. in Wloclawek, Poland on 12 October 2010. This event is the culmination of a series of investments initiated in the previous year for the targeted strategic development of this important location.
The company has achieved a new record for both Q3 order intake and order intake per September 30th. The positive development shows that we are well positioned for growth going forward, says Kenneth Ragnvaldsen, CEO of Data Respons ASA.
Operating revenue in the 3rd quarter was NOK 154.0 million. EBITDA was NOK 1.7 million and EBIT was NOK 0.1 million. The order intake was NOK 202 million, a growth of 76 %.
Operating revenue for the first 9 months was NOK 502.5 million. EBITDA was
Pumacy Technologies AG takes part in the collaborative research project"Vertumnus – early diagnosis, measurement, evaluation, and design of change in value creation networks"funded by the Federal Ministry of Education and Research (BMBF).
10 – .
– Patent expiries and new wave of drug budget controls subdue growth among brands in developed markets
– Pharmerging countries contribute nearly half of total growth, with China as world?s third-largest market
– Innovative products poised to provide new treatment options
The value of the global pharmaceutical market is expected to grow 5-7 percent in 2011, to US$880 billion, compared with a 4-5 percent pace this year, according to IMS Health. The forecast,
